Related references
Note: Only part of the references are listed.Dual inhibition of factor XIIa and factor XIa as a therapeutic approach for safe thromboprotection
Stephanie Demoulin et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2021)
Factor XII plays a pathogenic role in organ failure and death in baboons challenged with Staphylococcus aureus
Robert Silasi et al.
BLOOD (2021)
Associations of coagulation factor X and XI with incident acute coronary syndrome and stroke: A nested case-control study
Huiting Chen et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2021)
The rebirth of the contact pathway: a new therapeutic target
Priyanka Srivastava et al.
CURRENT OPINION IN HEMATOLOGY (2020)
Subclinical Leaflet Thrombosis in Transcatheter and Surgical Bioprosthetic Valves PARTNER 3 Cardiac Computed Tomography Substudy
Raj R. Makkar et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2020)
Subclinical Thrombosis of Bioprosthetic Aortic Valves
Gennaro Giustino et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2020)
Cyclic peptide FXII inhibitor provides safe anticoagulation in a thrombosis model and in artificial lungs
Jonas Wilbs et al.
NATURE COMMUNICATIONS (2020)
Factor XII in PMM2-CDG patients: role of N-glycosylation in the secretion and function of the first element of the contact pathway
Raquel Lopez-Galvez et al.
ORPHANET JOURNAL OF RARE DISEASES (2020)
The FXII c.-4T>C Polymorphism as a Disease Modifier in Patients With Hereditary Angioedema Due to the FXII p.Thr328Lys Variant
Fernando Corvillo et al.
FRONTIERS IN GENETICS (2020)
Antibody inhibition of contact factor XII reduces platelet deposition in a model of extracorporeal membrane oxygenator perfusion in nonhuman primates
Michael Wallisch et al.
RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS (2020)
Intrinsic Pathway of Coagulation and Thrombosis: Insights From Animal Models
Steven P. Grover et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2019)
Gynaecological and obstetrical bleeding in Caucasian women with congenital factor XI deficiency: Results from a twenty-year, retrospective, observational study
Carlos Bravo-Perez et al.
MEDICINA CLINICA (2019)
The Safety and Efficacy of Novel Agents Targeting Factors XI and XII in Early Phase Human Trials
Emma P. DeLoughery et al.
SEMINARS IN THROMBOSIS AND HEMOSTASIS (2019)
Roles of Factor XII in Innate Immunity
Thomas Renne et al.
FRONTIERS IN IMMUNOLOGY (2019)
Assessment of Platelet REACtivity After Transcatheter Aortic Valve Replacement The REAC-TAVI Trial
Victor Alfonso Jimenez Diaz et al.
JACC-CARDIOVASCULAR INTERVENTIONS (2019)
Is There a Link Between Stroke, Anticoagulation, and Platelet Reactivity? The Multifactorial Stroke Mechanism Following TAVR
Victor Alfonso Jimenez Diaz et al.
JACC-CARDIOVASCULAR INTERVENTIONS (2019)
2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC)
Borja Ibanez et al.
EUROPEAN HEART JOURNAL (2018)
Coagulation factor XII in thrombosis and inflammation
Coen Maas et al.
BLOOD (2018)
Factor XI deficiency is associated with lower risk for cardiovascular and venous thromboembolism events
Meir Preis et al.
BLOOD (2017)
High incidence of FXI deficiency in a Spanish town caused by 11 different mutations and the first duplication of F11: Results from the Yecla study
J. Esteban et al.
HAEMOPHILIA (2017)
Factor XII Contact Activation
Clement Naudin et al.
SEMINARS IN THROMBOSIS AND HEMOSTASIS (2017)
Factor XII-Driven Inflammatory Reactions with Implications for Anaphylaxis
Lysann Bender et al.
FRONTIERS IN IMMUNOLOGY (2017)
The Effects of the Contact Activation System on Hemorrhage
Fabricio Simao et al.
FRONTIERS IN MEDICINE (2017)
Plasmin is a natural trigger for bradykinin production in patients with hereditary angioedema with factor XII mutations
Steven de Maat et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2016)
Contact system revisited: an interface between inflammation, coagulation, and innate immunity
A. T. Long et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2016)
Factor XI Antisense Oligonucleotide for Prevention of Venous Thrombosis
Harry R. Bueller et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Selective depletion of factor XI or factor XII with antisense oligonucleotides attenuates catheter thrombosis in rabbits
Jonathan W. Yau et al.
BLOOD (2014)
MutationTaster2: mutation prediction for the deep-sequencing age
Jana Marie Schwarz et al.
NATURE METHODS (2014)
Aortic Stenosis in the Elderly Disease Prevalence and Number of Candidates for Transcatheter Aortic Valve Replacement: A Meta-Analysis and Modeling Study
Ruben L. J. Osnabrugge et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2013)
A nanobody-based method for tracking factor XII activation in plasma
Steven de Maat et al.
THROMBOSIS AND HAEMOSTASIS (2013)
Vascular Complications After Transcatheter Aortic Valve Replacement
Philippe Genereux et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2012)
NIH Image to ImageJ: 25 years of image analysis
Caroline A. Schneider et al.
NATURE METHODS (2012)
Valvular heart disease: the next cardiac epidemic
J. L. d'Arcy et al.
HEART (2011)
Patients with severe factor XI deficiency have a reduced incidence of deep-vein thrombosis
Ophira Salomon et al.
THROMBOSIS AND HAEMOSTASIS (2011)
Isolated aortic valve replacement in North America comprising 108,687 patients in 10 years: Changes in risks, valve types, and outcomes in the Society of Thoracic Surgeons National Database
James M. Brown et al.
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY (2009)
Elevated factor XI activity levels are associated with an increased odds ratio for cerebrovascular events
David T. Yang et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2006)
Defective thrombus formation in mice lacking coagulation factor XII
T Renné et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Targeted deletion of murine coagulation factor XII gene-a model for contact phase activation in vivo
HU Pauer et al.
THROMBOSIS AND HAEMOSTASIS (2004)
High levels of coagulation factor XI as a risk factor for venous thrombosis.
JCM Meijers et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
Share Paper
